Clinical Trial Update: Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of a pioglitazone/metformin combination in adults with type 2 diabetes mellitus and dyslipidemia; results from the complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• metformin (metformin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus, Dyslipidemias | Phase 3 | Status: COMPLETED | Results posted: 2010-10-06